Skip to main content
. 2015 Oct 3;6(32):32669–32680. doi: 10.18632/oncotarget.5404

Figure 5. The prognostic impact of CD21 expression in CLL.

Figure 5

A. The median expression of CD21 was determined and the cohort was categorized into CD21lo and CD21hi subsets. CLL patients with a CD21hi phenotype had a significantly inferior outcome when compared to CD21lo patients.